Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
575 SEK | +3.23% |
|
+1.95% | +6.88% |
May. 23 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
May. 23 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.88% | 3.1B | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Camurus' Rare Growth Disorder Drug Accepted for Review in EU